Literature DB >> 818383

E1j, a quantitative variant at cholinesterase locus 1: immunological evidence.

H M Rubinstein, A A Dietz, T Lubrano, P J Garry.   

Abstract

Sera of various phenotypes at serum cholinesterase locus 1, including the newly recognized phenotypes E1 aE1j, E1 uE1j, and E1 fE1J, were studied by immunodiffusion and rocket immunoelectrophoresis. The sera containing the E1j allele show reduced numbers of immunologically active cholinesterase molecules. This finding is consistent with the previously advanced hypothesis that E1j results in reduced numbers of circulating 'usual' (E1u) molecules. Whether this reduction is the result of the low rate of synthesis or of an increased rate of degradation of the cholinesterase remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 818383      PMCID: PMC1013348          DOI: 10.1136/jmg.13.1.43

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocholine-dithiobis(nitrobenzoic acid)procedure.

Authors:  A A Dietz; H M Rubinstein; T Lubrano
Journal:  Clin Chem       Date:  1973-11       Impact factor: 8.327

2.  Improved method for the differentiation of cholinesterase variants.

Authors:  A A Dietz; H M Rubinstein; T Lubrano; L K Hodges
Journal:  Am J Hum Genet       Date:  1972-01       Impact factor: 11.025

3.  A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity.

Authors:  A Yoshida; A G Motulsky
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

4.  Differing methodology and equations used in quantitating immunoglobulins by radial immunodiffusion--a comparative evaluation of reported and commercial techniques.

Authors:  B H Berne
Journal:  Clin Chem       Date:  1974       Impact factor: 8.327

5.  Silent cholinesterase gene: variations in the properties of serum enzyme in apparent homozygotes.

Authors:  H M Rubinstein; A A Dietz; L K Hodges; T Lubrano; V Czebotar
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

6.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

7.  Increased plasma cholinesterase activity and succinylcholine resistance: a genetic variant.

Authors:  H W Neitlich
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

  7 in total
  8 in total

1.  New allele at cholinesterase locus 1.

Authors:  P J Garry; A A Dietz; T Lubrano; P C Ford; K James; H M Rubinstein
Journal:  J Med Genet       Date:  1976-02       Impact factor: 6.318

2.  DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

Authors:  C F Bartels; F S Jensen; O Lockridge; A F van der Spek; H M Rubinstein; T Lubrano; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

3.  E1k, another quantitative variant at cholinesterase locus 1.

Authors:  H M Rubinstein; A A Dietz; T Lubrano
Journal:  J Med Genet       Date:  1978-02       Impact factor: 6.318

4.  Immunological comparison of the usual and atypical human serum cholinesterase phenotypes.

Authors:  H W Eckerson; A Oseroff; O Lockridge; B N La Du
Journal:  Biochem Genet       Date:  1983-02       Impact factor: 1.890

5.  A family segregating for E1j and E1k at cholinesterase locus 1.

Authors:  R T Evans; J Iqbal; A A Dietz; T Lubrano; H M Rubinstein
Journal:  J Med Genet       Date:  1980-12       Impact factor: 6.318

6.  DNA mutations associated with the human butyrylcholinesterase J-variant.

Authors:  C F Bartels; K James; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

7.  Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.

Authors:  S L Primo-Parmo; C F Bartels; B Wiersema; A F van der Spek; J W Innis; B N La Du
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

8.  Suxamethonium-the development of a modern drug from 1906 to the present day.

Authors:  H R Dorkins
Journal:  Med Hist       Date:  1982-04       Impact factor: 1.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.